Impact and significance of compulsory licensing for access to medicine
by Gargi Chakrabarti
International Journal of Intellectual Property Management (IJIPM), Vol. 8, No. 3/4, 2015

Abstract: Affordability and accessibility is a serious concern for the world today, patients from developing and least developed countries cannot afford the costly patented medicine, even if they are in urgent need. Thus, people cannot exercise their right to health properly. TRIPS given compulsory licensing flexibility, but implementation of that is difficult. It is debatable whether this flexibility is effective for access to medicine. This paper will scrutinise all relevant aspects of this matter and will try to suggest possible solutions.

Online publication date: Thu, 12-May-2016

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Intellectual Property Management (IJIPM):
Login with your Inderscience username and password:

Username:        Password:          Forgotten your password?

Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com